US Stock MarketDetailed Quotes
BMRN Biomarin Pharmaceutical
- 80.980
- -1.150-1.40%
Trading Apr 30 10:33 ET
15.38BMarket Cap76.40P/E (TTM)
81.790High80.700Low255.00KVolume81.790Open82.130Pre Close20.69MTurnover0.14%Turnover Ratio93.08P/E (Static)189.88MShares99.56052wk High3.03P/B15.26BFloat Cap76.02052wk Low--Dividend TTM188.42MShs Float151.750Historical High--Div YieldTTM1.33%Amplitude3.570Historical Low81.154Avg Price1Lot Size
Biomarin Pharmaceutical Key Stats
EPS
According to the latest financial report of Biomarin Pharmaceutical, the latest earnings per share (TTM) for the company is 0.46. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Biomarin Pharmaceutical's free cash flow? The latest report shows it as 12.87M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Biomarin Pharmaceutical shows that the company's current ratio is 2.74, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Biomarin Pharmaceutical, the quick ratio is 1.55, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of Biomarin Pharmaceutical? The latest ROE figure is 1.77%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Biomarin Pharmaceutical, the total asset return on investment (ROA) is 1.29%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Biomarin Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 80.71%.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Biomarin Pharmaceutical, the net profit margin is 13.66%, which is a good sign for its profitability.
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg